A large proportion of US adults at risk for CKD have undetected albuminuria, indicating a critical need for improved screening to prevent CKD progression and cardiovascular complications.
In this cohort study of patients with hypertension or diabetes, it was estimated that approximately two-thirds of patients with albuminuria were undetected due to lack of testing. These results suggest that improving detection of CKD with albuminuria testing represents a substantial opportunity to optimize care delivery for reducing CKD progression and cardiovascular complications.
Chu et al. (Thu,) studied this question.